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Members of *Streptomyces* genus have received considerable attention and sparked interest among pharmaceutical industry as they are capable of synthesizing compounds of diverse structures with bioactivities including antibiotics, anti-rejection (immunosuppressant), antioxidant and anticancer.[@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095] *Streptomyces mangrovisoli* MUSC 149^T^ was previously isolated as a novel streptomycete with antioxidant potential from mangrove forest in east coast of Peninsular Malaysia[@bib0100], [@bib0105] and the strain has been deposited at two culture collection centers (=MCCC 1K00252^T^ = DSM 42140^T^). Thus, the strain MUSC 149^T^ was selected for genome sequencing as an attempt to identify biosynthetic gene clusters associated with secondary metabolite production.

The genomic DNA of MUSC 149^T^ was extracted with Masterpure™ DNA purification kit (Epicentre, Illumina Inc., Madison, WI, USA) followed by RNase (Qiagen, USA) treatment.[@bib0110], [@bib0115] DNA quality was examined using NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA, USA) and a Qubit version 2.0 fluorometer (Life Technologies, Carlsbad, CA, USA). Subsequently, DNA library was constructed using Nextera™ DNA Sample Preparation kit (Nextera, USA) and the library quality was validated by Bioanalyzer 2100 high sensitivity DNA kit (Agilent Technologies, Palo Alto, CA) before performing paired-end on MiSeq platform with MiSeq Reagent Kit 2 (2× 250 bp; Illumina Inc., Madison, WI, USA). The paired-end reads were trimmed and *de novo* assembled with CLC Genomics Workbench version 7 (CLC bio, Denmark). The analysis generated 199 contigs with N~50~ size of 108,867 bp ([Table 1](#tbl0005){ref-type="table"}). The assembled genome size of MUSC 149^T^ contained 9,165,825 bp, with an average coverage of 119.0-fold and G+C content of 72.5%. The whole genome project of MUSC 149^T^ was deposited at DDBJ/EMBL/GenBank under accession number LAVA00000000 and the version described in this paper is the second version (LAVA02000000).Table 1General features of *Streptomyces mangrovisoli* MUSC 149^T^ genome.Table 1*Streptomyces mangrovisoli* MUSC 149^T^Genome size (bp)9,165,825Contigs199Contigs N~50~ (bp)108,867G+C content %72.5Protein coding genes7461tRNA69rRNA4 (5S),1 (16S),1 (23S)

Gene prediction was performed using Prodigal version 2.6, whereas rRNA and tRNA were predicted using RNAmmer and tRNAscan SE version 1.21.[@bib0120], [@bib0125], [@bib0130] The assembly was uploaded for annotation to Rapid Annotation using Subsystem Technology (RAST).[@bib0135] A total of 7461 protein-encoding genes was predicted and assigned to 442 subsystems, along with 69 tRNA and 6 rRNA genes ([Fig. 1](#fig0005){ref-type="fig"}). Among the subsystems, most of the genes were involved in amino acids and derivatives metabolism (8.97%), followed by carbohydrates metabolism (8.40%) and cofactors, vitamins, prosthetic groups, pigments metabolism subsystems (4.91%).Fig. 1Subsystem category distribution of *Streptomyces mangrovisoli* MUSC 149^T^ (based on RAST annotation server).

In order to investigate its bioactive potential, the genome of MUSC 149^T^ was further analyzed using antibiotics & Secondary Metabolite analysis shell (antiSMASH) version 3.0.[@bib0140] The antiSMASH server revealed 21 gene clusters related to antibiotics and secondary metabolite biosynthesis, with four clusters showed more than 70% similarities to known gene clusters: venezuelin biosynthetic gene cluster (75%), ectoine biosynthetic gene cluster (75%), desferrioxamine B biosynthetic gene cluster (83%), and hopene biosynthetic gene cluster (85%). Previously, extract of MUSC 149^T^ was found to possess antioxidant activity; the presence of siderophores biosynthetic gene clusters such as desferrioxamine B has further highlight the antioxidant potential of strain MUSC 149^T^.

In conclusion, we report the draft genome sequence of *S. mangrovisoli* MUSC 149^T^. The availability of its genome sequence has revealed production of potentially medically useful compounds and certainly deserves further detailed study.
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